Orencia clickject 125 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FV7X7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,634
Award facts
- Contract value 100% obligated
- $26,634.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $26,634.13, awards AmerisourceBergen Drug Corp pharmaceutical supply for Orencia ClickJect 125 mg/mL, an injectable rheumatoid arthritis treatment. Awarded by the Defense Logistics Agency on January 21, 2026, with an ultimate completion date of January 22, 2026, this firm fixed-price contract involves no set-aside designation and will be performed in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains. The company's extensive contract history with the Defense Logistics Agency demonstrates its capability to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities on a competitive, non-set-aside basis. This delivery order for Orencia ClickJect supports the military and veteran healthcare systems' pharmaceutical requirements as part of the broader Pharmaceutical Prime Vendor program, which aims to provide flexible and comprehensive medical supply capabilities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FV7X7?
SPE2DR26FV7X7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV7X7 worth?
The government has obligated $26,634 on SPE2DR26FV7X7.
Is contract SPE2DR26FV7X7 an order under another contract?
Yes. SPE2DR26FV7X7 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7X7 competed?
The extent of competition for SPE2DR26FV7X7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award